K
Kenichiro Morisawa
Researcher at St. Marianna University School of Medicine
Publications - 20
Citations - 301
Kenichiro Morisawa is an academic researcher from St. Marianna University School of Medicine. The author has contributed to research in topics: ARDS & Medicine. The author has an hindex of 6, co-authored 19 publications receiving 246 citations.
Papers
More filters
Journal ArticleDOI
Toward Improved Surveillance: The Impact of Ventilator-Associated Complications on Length of Stay and Antibiotic Use in Patients in Intensive Care Units
Yoshiro Hayashi,Kenichiro Morisawa,Michael Klompas,Michael Klompas,Mark Jones,Hiran Bandeshe,Robert J. Boots,Jeffrey Lipman,David L. Paterson,David L. Paterson +9 more
TL;DR: VAC events were associated with significantly increased ICU length of stay, duration of mechanical ventilation, and consumption of broad-spectrum antibiotics but not with longer hospital stays or ICU mortality, suggesting VAC may be a useful surveillance tool.
Journal ArticleDOI
Early-phase changes of extravascular lung water index as a prognostic indicator in acute respiratory distress syndrome patients
Takashi Tagami,Takashi Tagami,Toshiaki Nakamura,Shigeki Kushimoto,Ryoichi Tosa,Akihiro Watanabe,Tadashi Kaneko,Hidetada Fukushima,Hiroshi Rinka,Daisuke Kudo,Hideaki Uzu,Akira Murai,Makoto Takatori,Hiroo Izumino,Yoichi Kase,Ryutarou Seo,Hiroyuki Takahashi,Yasuhide Kitazawa,Junko Yamaguchi,Manabu Sugita,Yuichi Kuroki,Takashi Kanemura,Kenichiro Morisawa,Nobuyuki Saito,Takayuki Irahara,Hiroyuki Yokota +25 more
TL;DR: Decrease in EVL Wi during the first 48 h of ARDS may be associated with 28-day survival, and Serial EVLWi measurements may be useful for understanding the pathophysiologic conditions in ARDS patients.
Journal ArticleDOI
The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
Yukitaka Yamasaki,Seido Ooka,Tomoya Tsuchida,Yuta Nakamura,Yuta Hagiwara,Yoshiyuki Naitou,Yuki Ishibashi,Hiroki Ikeda,Tsutomu Sakurada,Hiroshi Handa,Hiroki Nishine,Mumon Takita,Daiki Morikawa,Hideki Yoshida,Shuichi Fujii,Kenichiro Morisawa,Hiromu Takemura,Shigeki Fujitani,Hiroyuki Kunishima +18 more
TL;DR: Treatment with ciclesonide may prevent the development of severe COVID-19, and the lymphocyte count could be used to identify patients that may develop severe CO VID-19.
Journal ArticleDOI
Difference in pulmonary permeability between indirect and direct acute respiratory distress syndrome assessed by the transpulmonary thermodilution technique: a prospective, observational, multi-institutional study.
Kenichiro Morisawa,Shigeki Fujitani,Yasuhiko Taira,Shigeki Kushimoto,Yasuhide Kitazawa,Kazuo Okuchi,Hiroyasu Ishikura,Teruo Sakamoto,Takashi Tagami,Junko Yamaguchi,Manabu Sugita,Yoichi Kase,Takashi Kanemura,Hiroyuki Takahashi,Yuuichi Kuroki,Hiroo Izumino,Hiroshi Rinka,Ryutarou Seo,Makoto Takatori,Tadashi Kaneko,Toshiaki Nakamura,Takayuki Irahara,Nobuyuki Saitou,Akihiro Watanabe +23 more
TL;DR: The results of this study suggest the existence of several differences in the increased degree of pulmonary permeability between patients with ARDSexp and ARDSp.
Journal ArticleDOI
Positive clinical risk factors predict a high rate of methicillin-resistant Staphylococcus aureus colonization in emergency department patients
Haruaki Wakatake,Shigeki Fujitani,Takamitsu Kodama,Eiji Kawamoto,Hiroyuki Yamada,Machi Yanai,Kenichiro Morisawa,Hiromu Takemura,Alan T. Lefor,Yasuhiko Taira +9 more
TL;DR: The prevalence rate of colonization in patients with a high risk of MRSA colonization exceeded 30% and active surveillance cultures should be considered in patients at high risk for MRSA Colonization.